D-Sight
PrivateLast Round
VC Round
Feb 23, 2026
Total Funding Raised
$1.08M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
D-Sight is a biotechnology company developing neuroprotective eye drops for the treatment of retinal neurodegenerative diseases such as diabetic retinopathy and glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
D-Sight Comparables
Compare D-Sight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspecthera Pty Ltd | 86% | |
| Exonate | 84% | |
| Glucox Biotech AB | 84% | |
D-Sight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 23, 2026 | ||||
| Seed | May 2, 2023 |
Key People
Founding team and executive leadership
D-Sight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prous Institute for Biomedical Research | VC Round |
| Clave Capital | VC Round, Seed |
| Catalan Institute of Finance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
$2.36M round led by Clave Capital.
- Feb 2, 2026
Monthly visitors grew 36% MoM, reaching 1.3K.
D-Sight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about D-Sight's valuation, stock price, and market status.